New ipsogen BCR-ABL1 Mbcr RGQ RT-PCR Kit (CE)

New ipsogen BCR-ABL1 Mbcr RGQ RT-PCR Kit (CE)

Molecular Diagnostics

June 17, 2015

Qiagen is happy to announce the launch of the next CE-IVD assay for our PHC blood cancer portfolio: The ipsogen BCR-ABL1 Mbcr RGQ RT-PCR kit.

The ipsogen BCR-ABL1 Mbcr RGQ RT-PCR kit is an in-vitro diagnostic test to quantify the BCR-ABL1 fusion gene b3a2 (e14a2) and b2a2 (e13a2) transcripts in total RNA extracted from whole blood. It uses the RNeasy kit for extraction and runs on the Rotor-Gene Q MDx.

This is the first commercial kit to provide deep molecular response status for BCR-ABL1 transcripts present in patients diagnosed with chronic phase Philadelphia chromosome positive (Ph+) p210 chronic myeloid leukemia (CML). To achieve deep molecular response, quantification down to a limit of detection (LOD) lower than 0.0030% is required. The new ipsogen BCR-ABL1 Mbcr RGQ RT-PCR kit is hence the most sensitive commercial leukemia test on the market.
Such low levels of sensitivity are in-line with the latest oncohematology expert recommendations for the management of CML. If a patient under latest generation tyrosine kinase inhibitor therapy (e.g nilotinib) achieves deep molecular response, the levels of BCR-ABL1 in the blood are 4.5 logs, or 10,500 times, lower than they were before the treatment started. These patients are then considered to be in remission, and after a period of time may have the option of living free of drug therapy. This is another good example how QIAGEN sample-to-insight solutions can impact the treatment of life-threatening diseases such as leukemia and help to provide best therapy options for patients.

New QIAseq miRNA Library Kit overcomes miRNA-seq challenges

New QIAseq miRNA Library Kit overcomes miRNA-seq challenges

Molecular Diagnostics

microRNA sequencing is the future of gene regulation analysis, providing unmatched specificity for closely related microRNAs as well as the ability to detect novel noncoding transcripts. But challenges in the current workflow can cause up to half of microRNA sequencing data to be missed entirely.

 

January 04, 2017 More +
New Compact PF-3 Fish

New Compact PF-3 Fish

Molecular Diagnostics

To constantly provide a safe habitat for fish, the water quality has to be closely monitored.

 

 

January 25, 2016 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us